Skip to main content
OpenTrials

Clinical trial condition

Hematologic Neoplasms

Explore clinical trials studying Hematologic Neoplasms. Study availability and eligibility vary by location and protocol.

85 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

Hematologic Neoplasms trial results

Completed

A Study to Evaluate Safety, Pharmacokinetics, Pharmacodynamics and Preliminary Efficacy of the Combination of Ibrutinib With Nivolumab in Participants With Hematologic Malignancies

NCT02329847

Conditions
Hematologic Diseases, Hematologic Neoplasms, Hemic and Lymphatic Diseases, +2 more
Locations
  • New York, United States
  • Bedford Park, Australia
  • Darlinghurst, Australia
  • Woolloongabba, Australia
View all 18 locations
View Trial Details
Completed

Genomic Testing and Resulting Medical Decisions

NCT03301493

Conditions
Adenocarcinoma, Breast Diseases, Breast Neoplasms, +70 more
Locations
  • IIIrd Medical Department, Private Medical University Hospital Salzburg Salzburg, State of Salzburg, Austria
  • Innere Medizin II, LKH Feldkirch Feldkirch, Austria
  • Medizinische Universitaet Graz, Univ.-Klinik f. Innere Medizin, Onkologie Graz, Austria
  • Medizinische Universität Innsbruck Innsbruck, Austria
View Trial Details
Completed

Evaluation of ClearLLab LS Screening Panel

NCT05819762

Conditions
Hematologic Diseases, Hematologic Malignancy, Hematologic Neoplasms, +3 more
Locations
  • Tongji Hospital Wuhan, Hubei, China
  • The First Affiliated Hospital of Nanjing Medical University Nanjing, Jiangsu, China
  • The First Affiliated Hospital of Soochow University Suzhou, Jiangsu, China
  • Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Tianjin, China
View Trial Details

Related conditions